Abstract
A complex inflammatory cascade is an established part of the pathophysiology of Alzheimer’s disease (AD), and preliminary studies have suggested a link between systemic inflammation and AD. Recent research has extended this theme by examining the influence of systemic inflammation on cognitive function in community-dwelling elderly. Preliminary findings suggest that elevated levels of some inflammatory markers such as interleukin-6 (IL-6) and C-reactive protein (CRP) are associated with poorer cognition at cross-sectional assessment. Longitudinal studies suggest an impact of raised IL-6 and CRP, in terms of both cognitive decline and outcome of dementia. Although findings vary considerably between studies, systemic inflammation may have relevance for cognitive function and cognitive decline in late life. Further comprehensive studies are required to further explore the relationship between systemic inflammation and cognition in the elderly.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Ishii T, Haga S, Shimizu F (1975) Identification of components of immunoglobulins in senile plaques by means of fluorescent antibody technique. Acta Neuropathol 32:157–162
Rogers J, Luber-Narod J, Styren SD et al (1988) Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer’s disease. Neurobiol Aging 9:339–349
McGeer PL, Rogers J, McGeer E (2006) Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years. J Alzheimers Dis 9:271–276
Akiyama H, Bargers S, Barnum S et al (2000) Inflammation and Alzheimer’s disease. Neurobiol Aging 21:383–421
Breitner JC (1996) Inflammatory processes and antiinflammatory drugs in Alzheimer’s disease: a current appraisal. Neurobiol Aging 17:789–794
McGeer PL, Schulzer M, McGeer EG (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer’s disease: a review of 17 epidemiologic studies. Neurology 47:425–432
Wyss-Coray T (2006) Inflammation in Alzheimer’s disease: driving force, bystander or Âbeneficial response? Nat Med 12(9):1005–1015
Bermejo P, Martin-Aragon S, Benedi J et al (2008) Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer’s disease. Immunol Lett 117(2):198–202
Alvarez A, Cacabelos R, Sanpedro C et al (2007) Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer’s disease. Neurobiol Aging 28:533–536
Dimopoulos N, Piperi C, Salonicioti A et al (2006) Indices of low-grade chronic inflammation correlate with early cognitive deterioration in an elderly Greek population. Neurosci Lett 398(1–2):118–123
Zuliani G, Ranzini M, Guerra G et al (2007) Plasma cytokines profile in older subjects with late-onset Alzheimer’s disease or vascular dementia. J Psychiatr Res 41:686–693
Licastro F, Pedrini S, Caputo L et al (2000) Increased plasma levels of interleukin-1, interleukin-6 and α1-antichymotrypsin in patients with Alzheimer’s disease: peripheral inflammation or signals from the brain? J Neuroimmunol 103:97–102
Singh VK, Guthikonda P (1997) Circulating cytokines in Alzheimer’s disease. J Psychiatr Res 31(6):657–660
McGeer PL, McGeer EG (2001) Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Arch Neurol 58:1790–1792
Papassotiropolous A (1999) A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer’s disease. Ann Neurol 45:666–668
Luterman JD, Haroutunian V, Yemul S et al (2000) Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia. Arch Neurol 57:1153–1160
McCusker SM, Curran MD, Dynan KB (2001) Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer’s disease and vascular dementia: a case-control study. Lancet 357(9254):436–439
Nicoll JA, Mrak RE, Graham DI et al (2000) Association of interleukin-1 gene polymorphisms with Alzheimer’s disease. Ann Neurol 47(3):365–368
Franceschi C, Capri M, Monti D et al (2007) Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 128:92–105
Giunta B, Fernandez F, Nikolic WV et al (2008) Inflammaging as a prodrome to Alzheimer’s disease. J Neuroinflammation 5:51–66
Sparkman NL, Johnson RW (2008) Neuroinflammation associated with aging sensitizes the brain to the effects of infection and stress. Neuroimmunomodulation 15:323–330
Wilson CJ, Finch CE, Cohen HJ (2002) Cytokines and cognition: the case for a head-to-toe paradigm. J Am Geriatr Soc 50:2041–2056
Alley DE, Crimmins EM, Karlamangla A et al (2008) Inflammation and rate of cognitive change in high-functioning older adults. J Gerontol A Biol Sci Med Sci 63A(1):50–55
Baune BT, Ponath G, Golledge J et al (2008) Association between IL-8 cytokine and cognitive performance in an elderly general population: the MEMO-study. Neurobiol Aging 29:937–944
Sweat V, Starr V, Bruehl H (2008) C-reactive protein is linked to lower cognitive performance in overweight and obese women. Inflammation 31(3):198–207
Schram MT, Euser SM, de Craen AJM et al (2007) Systemic markers of inflammation and cognitive decline in old age. J Am Geriatr Soc 55:708–716
Fischer P, Zehetmayer S, Bauer K et al (2006) Relation between vascular risk factors and cognition at age 75. Acta Neurol Scand 114:84–90
Dik MG, Jonker C, Hack CE et al (2005) Serum inflammatory proteins and cognitive decline in older persons. Neurology 64:1371–1377
Ravaglia G, Forti P, Maioli F et al (2005) Serum C-reactive protein and cognitive function in healthy elderly Italian community dwellers. J Gerontol A Biol Sci Med Sci 60A(8):1017–1021
Elwan O, Madkour O, Elwan F et al (2003) Brain aging in normal Egyptians: cognition, Âeducation, personality, genetic and immunological study. J Neurol Sci 211:15–22
Teunissen CE, van Boxtel MPJ, Bosma H et al (2003) Inflammation markers in relation to cognition in a healthy aging population. J Neuroimmunol 134:142–150
Weaver JD, Huang MH, Albert M et al (2002) Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 59:371–378
Bruunsgaard H, Andersen-Ranberg K, Jeune B et al (1999) A high plasma concentration of TNF-α is associated with dementia in centenarians. J Gerontol A Biol Sci Med Sci 54A(7):357–364
Haan MN, Aiello AE, West NA et al (2008) C-reactive protein and rate of dementia in carriers and non carriers of apolipoprotein APOE4 genotype. Neurobiol Aging 29:1774–1782
Jordanova V, Stewart R, Davies E et al (2007) Markers of inflammation and cognitive decline in an African-Caribbean population. Int J Geriatr Psychiatry 22:966–973
Komulainen P, Lakka TA, Kivipelto M et al (2007) Serum high sensitivity C-reactive protein and cognitive function in elderly women. Age Ageing 36:443–448
Rafnsson SB, Deary IJ, Smith FB et al (2007) Cognitive decline and markers of inflammation and hemostasis: the Edinburgh artery study. J Am Geriatr Soc 55:700–707
Ravaglia G, Forti P, Maioli F et al (2007) Blood inflammatory markers and risk of dementia: the Conselice study of brain aging. Neurobiol Aging 28:1810–1820
Tan ZS, Beiser AS, Vasan RS et al (2007) Inflammatory markers and the risk of Alzheimer’s disease: the Framingham study. Neurology 68:1902–1908
Van den Biggelaar AHJ, Gussekloo J, de Craen AJM et al (2007) Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. Exp Gerontol 42:693–701
Weuve J, Ridker PM, Cook NR et al (2006) High-sensitivity C-reactive protein and cognitive function in older women. Epidemiology 17:183–189
Tilvis RS, Kahonen-Vare MH, Jolkkonen J et al (2004) Predictors of cognitive decline and mortality of aged people over a 10-year period. J Gerontol A Biol Sci Med Sci 59A(3):268–274
Yaffe K, Kanaya A, Lindquist K et al (2004) The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292(18):2237–2242
Engelhart M, Geerlings MI, Meijer J et al (2004) Inflammatory proteins in plasma and the risk of dementia. Arch Neurol 61:668–672
Schmidt R, Schmidt H, Curb D et al (2002) Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia aging study. Ann Neurol 52:168–174
Gimeno D, Marmot MG, Singh et al (2008) Inflammatory markers and cognitive function in middle-aged adults: the Whitehall II study. Psychoneuroendocrinology 33:1322–1334
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer
About this chapter
Cite this chapter
Trollor, J., Agars, E. (2010). Systemic Inflammation and Cognition in the Elderly. In: Miyoshi, K., Morimura, Y., Maeda, K. (eds) Neuropsychiatric Disorders. Springer, Tokyo. https://doi.org/10.1007/978-4-431-53871-4_13
Download citation
DOI: https://doi.org/10.1007/978-4-431-53871-4_13
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-53870-7
Online ISBN: 978-4-431-53871-4
eBook Packages: MedicineMedicine (R0)